1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
2011.61(2): 69–90
|
2
|
Friedman SL: Molecular mechanisms of
hepatic fibrosis and principles of therapy. J Gastroenterol.
32:424–430. 1997. View Article : Google Scholar : PubMed/NCBI
|
3
|
Elsharkawy AM and Mann DA: Nuclear
factor-kappa B and the hepatic inflammation-fibrosis-cancer axis.
Hepatology. 46:590–597. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wong CM and Ng IO: Molecular pathogenesis
of hepatocellular carcinoma. Liver Int. 28:160–174. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Chau KY, Lily MA, Wu PC and Yau WL:
Myofibroblasts in hepatitis B related cirrhosis and hepatoellular
carcinoma. J Clin Pathol. 45:446–448. 1992. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bridle KR, Crawford DH, Powell LW and Ramm
GA: Role of myofibroblasts in tumor encapsulation of hepatocelluar
carcinoma in haemochromatosis. Liver. 21:96–104. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Terada T, Makimoto K, Terayama N, Suzuki Y
and Nakanuma Y: Alpha-smooth muscle actin-positive stroma cells in
cholangiocarcinomas, hepatocellular carcinomas and metastatic liver
careinomas. J Hepatol. 24:706–712. 1996. View Article : Google Scholar
|
8
|
Olaso E, Salado C, Egilegor E, et al:
Proangiogenic role of tumor-activated HSCs in experimental melanoma
metastasis. Hepatology. 37:674–685. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhao W, Zhang L, Yin Z, et al: Activated
HSCs promote hepatocellular carcinoma development in
immunocompetent mice. Int J Cancer. 129:2651–2661. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xia Y, Chen R, Song Z, Ye S, Sun R, Xue Q
and Zhang Z: Gene expression profiles during activation of cultured
rat HSCs by tumoral hepatocytes and fetal bovine serum. J Cancer
Res Clin Oncol. 136:309–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Weiskirchen R and Gressner AM: Isolation
and culture of HSCs. Methods Mol Med. 117:99–113. 2005.PubMed/NCBI
|
12
|
Geerts A: On the origin of stellate cells:
mesodermal, endodermal or neuro-ectodermal? J Hepatol. 40:331–334.
2004. View Article : Google Scholar
|
13
|
Bachem MG, Meyer D, Melchior R, Sell KM
and Gressner AM: Activation of rat liver perisinusoidal lipocytes
by transforming growth factors derived from myofibroblastlike
cells. A potential mechanism of self perpetuation in liver
fibrogenesis. J Clin Invest. 89:19–27. 1992. View Article : Google Scholar
|
14
|
Rockey DC, Boyles JK, Gabbiani G and
Friedman SL: Rat hepatic lipocytes express smooth muscle actin upon
activation in vivo and in culture. J Submicrosc Cytol Pathol.
4:193–203. 1992.PubMed/NCBI
|
15
|
Amann T, Bataille F, Spruss T, et al:
Activated HSCs promote tumorigenicity of hepatocellular carcinoma.
Cancer Sci. 100:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Neaud V, Faouzi S, Guirouilh J, Le Bail B,
Balabaud C, Bioulac-Sage P and Rosenbaum J: Human hepatic
myofibroblasts increase invasiveness of hepatocellular carcinoma
cells: evidence for a role of hepatocyte growth factor. Hepatology.
26:1458–1466. 1997. View Article : Google Scholar
|
17
|
Meindl-Beinker NM, Katsuzaki K and Dooley
S: TGF-β signaling in the onset and progression of hepatocellular
cancer. Dig Dis. 30:514–523. 2012.
|
18
|
Ogunwobi OO and Liu C: Hepatocyte growth
factor upregulation promotes carcinogenesis and
epithelial-mesenchymal transition in hepatocellular carcinoma via
Akt and COX-2 pathways. Clin Exp Metast. 28:721–731. 2011.
View Article : Google Scholar
|
19
|
Santomato A, Franseva E, Dituri F, et al:
HSCs stimulate HCC cell migration via laminin-5 production. Clin
Sci (Lond). 121:159–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kim SW, Kim JS, Papadopoulos J, et al:
Consistent interactions between tumor cell IL-6 and macrophage
TNF-alpha enhance the growth of human prostate cancer cells in the
bone of nude mouse. Int Immunopharmacol. 11:862–872. 2011.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Kao JT, Lai HC, Tsai SM, et al: Rather
than interleukin-27, interleukin-6 expresses positive correlation
with liver severity in naïve hepatitis B infection patients. Liver
Int. 32:928–936. 2012.PubMed/NCBI
|
22
|
Okazaki I and Inagaki Y: Novel strategies
for hepatocellular carcinoma based on MMPs science. Anticancer
Agents Med Chem. 12:753–763. 2012. View Article : Google Scholar : PubMed/NCBI
|